SG11201407544XA - Composition for treatment of warts - Google Patents
Composition for treatment of wartsInfo
- Publication number
- SG11201407544XA SG11201407544XA SG11201407544XA SG11201407544XA SG11201407544XA SG 11201407544X A SG11201407544X A SG 11201407544XA SG 11201407544X A SG11201407544X A SG 11201407544XA SG 11201407544X A SG11201407544X A SG 11201407544XA SG 11201407544X A SG11201407544X A SG 11201407544XA
- Authority
- SG
- Singapore
- Prior art keywords
- international
- acid
- warts
- designated states
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Birds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Cosmetics (AREA)
Abstract
(12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date 5 December 2013 (05.12.2013) WIPOIPCT (10) International Publication Number WO 2013/180606 A1 (51) International Patent Classification: A61K8/36 (2006.01) A61K31/19 (2006.01) A61K 9/00 (2006.01) A61P17/12 (2006.01) A61K 9/08 (2006.01) (21) International Application Number: (22) International Filing Date: (25) Filing Language: (26) Publication Language: PCT/SE2012/050566 28 May 2012 (28.05.2012) English English (71) Applicant (for all designated States except US): ABBEX AB [SE/SE]; Ostermalmsgatan 19, S-114 26 Stockholm (SE). (72) Inventor; and (75) Inventor/Applicant (for US only)-. LICHT, Flemming [DK/DK]; Bogholder Alle 9st, DK-2720 Vanlose (DK). (74) Agent: LUNDQUIST, Tomas; AWAPATENT AB, P O Box 45086, S-104 30 Stockholm (SE). (81) Designated States (unless otherwise indicated, for every kind of national protection available)'. AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (84) Designated States (unless otherwise indicated, for every kind of regional protection available)'. ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG). Published: — with international search report (Art. 21(3)) V© o o 00 i-H o CJ (54) Title: COMPOSITION FOR TREATMENT OF WARTS (57) Abstract: The present invention concerns pharmaceutical composition comprising formic acid and a at least one C1-C4 alkyl ester of lactic acid, malic acid, tartaric acid, citric acid, preferably ethyl lactate, for the topical treatment of warts.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/SE2012/050566 WO2013180606A1 (en) | 2012-05-28 | 2012-05-28 | Composition for treatment of warts |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201407544XA true SG11201407544XA (en) | 2014-12-30 |
Family
ID=49673684
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201407544XA SG11201407544XA (en) | 2012-05-28 | 2012-05-28 | Composition for treatment of warts |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US10716857B2 (en) |
| JP (1) | JP5934437B2 (en) |
| KR (1) | KR101988693B1 (en) |
| CN (1) | CN104363885A (en) |
| AU (1) | AU2012381141B2 (en) |
| BR (1) | BR112014029590A2 (en) |
| CA (1) | CA2871990C (en) |
| EA (1) | EA026621B1 (en) |
| HK (1) | HK1206633A1 (en) |
| IL (1) | IL235367B (en) |
| MX (1) | MX351512B (en) |
| SG (1) | SG11201407544XA (en) |
| UA (1) | UA111785C2 (en) |
| WO (1) | WO2013180606A1 (en) |
| ZA (1) | ZA201409502B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR3018687B1 (en) * | 2014-03-19 | 2017-04-14 | Patrick Lepeytre | "COMPOSITION BASED ON CARBOXYLIC ACIDS AND ITS APPLICATION FOR THE TREATMENT OF HYPERKERATOSES" - |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN86107485A (en) * | 1986-10-29 | 1988-05-11 | 陈黄平 | Technique for transforming common white spirit into famous and perfuming spirits |
| US5433950A (en) | 1990-05-07 | 1995-07-18 | Schering-Plough Healthcare Products, Inc. | Flexible collodion compositions |
| US5476664A (en) * | 1994-04-15 | 1995-12-19 | Leonard Bloom | Treatment of warts using anthralins and occlusion |
| SE513436C2 (en) * | 1999-01-21 | 2000-09-11 | Astrid Agholme | Use of a formulation containing formic acid for the manufacture of a medicament for the treatment of warts, caused by Papillomavirus |
| US7780992B2 (en) | 2002-12-08 | 2010-08-24 | Tareq Abduljalil Albahri | Antiviral medicament |
| US20060110415A1 (en) * | 2004-11-22 | 2006-05-25 | Bioderm Research | Topical Delivery System for Cosmetic and Pharmaceutical Agents |
| KR20060104011A (en) * | 2005-03-29 | 2006-10-09 | 바이오이퀄 아게 | Topical formulation to be applied to wart removal, nail-disease treatment and nail care |
| CN1939539A (en) * | 2005-09-29 | 2007-04-04 | 瑞士商拜欧伊果公司 | Local prescription for wart, nail-disease treatment and nail care |
| US8691247B2 (en) * | 2006-12-26 | 2014-04-08 | Ad Lunam Labs Inc. | Skin rejuvenation cream |
| PL2190425T3 (en) | 2007-04-20 | 2016-04-29 | Bioequal Ag | Topically applicable fungicide agents for treating nails |
| JP5248040B2 (en) | 2007-05-25 | 2013-07-31 | リードケミカル株式会社 | Patch containing 5-methyl-1-phenyl-2- (1H) -pyridone |
| NL2003419C2 (en) * | 2009-09-01 | 2011-03-02 | Shieldmark Zacco | Composition for tropical application, uses thereof, applicator device and kit of parts. |
| EP2460509B1 (en) * | 2010-12-06 | 2017-11-15 | Abbex Ab | Composition for the treatment of warts |
-
2012
- 2012-05-28 US US14/403,007 patent/US10716857B2/en active Active
- 2012-05-28 MX MX2014014278A patent/MX351512B/en active IP Right Grant
- 2012-05-28 UA UAA201412210A patent/UA111785C2/en unknown
- 2012-05-28 SG SG11201407544XA patent/SG11201407544XA/en unknown
- 2012-05-28 AU AU2012381141A patent/AU2012381141B2/en active Active
- 2012-05-28 CA CA2871990A patent/CA2871990C/en active Active
- 2012-05-28 CN CN201280073392.3A patent/CN104363885A/en active Pending
- 2012-05-28 EA EA201491927A patent/EA026621B1/en not_active IP Right Cessation
- 2012-05-28 KR KR1020147032058A patent/KR101988693B1/en active IP Right Grant
- 2012-05-28 JP JP2015513968A patent/JP5934437B2/en active Active
- 2012-05-28 WO PCT/SE2012/050566 patent/WO2013180606A1/en active Application Filing
- 2012-05-28 BR BR112014029590A patent/BR112014029590A2/en not_active Application Discontinuation
-
2014
- 2014-10-28 IL IL235367A patent/IL235367B/en active IP Right Grant
- 2014-12-23 ZA ZA2014/09502A patent/ZA201409502B/en unknown
-
2015
- 2015-07-31 HK HK15107371.7A patent/HK1206633A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EA026621B1 (en) | 2017-04-28 |
| CA2871990A1 (en) | 2013-12-05 |
| AU2012381141B2 (en) | 2017-08-31 |
| US20150165031A1 (en) | 2015-06-18 |
| AU2012381141A1 (en) | 2014-12-18 |
| MX2014014278A (en) | 2015-06-04 |
| CN104363885A (en) | 2015-02-18 |
| MX351512B (en) | 2017-10-17 |
| IL235367B (en) | 2019-05-30 |
| KR20150035533A (en) | 2015-04-06 |
| EA201491927A1 (en) | 2015-05-29 |
| HK1206633A1 (en) | 2016-01-15 |
| IL235367A0 (en) | 2014-12-31 |
| NZ702424A (en) | 2017-02-24 |
| CA2871990C (en) | 2019-07-23 |
| KR101988693B1 (en) | 2019-06-12 |
| US10716857B2 (en) | 2020-07-21 |
| UA111785C2 (en) | 2016-06-10 |
| BR112014029590A2 (en) | 2017-06-27 |
| ZA201409502B (en) | 2017-06-28 |
| JP2015517570A (en) | 2015-06-22 |
| JP5934437B2 (en) | 2016-06-15 |
| WO2013180606A1 (en) | 2013-12-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201811148SA (en) | Cell penetrating peptide (cpp)-mediated ev loading | |
| SG11201407200TA (en) | Liquid formulation | |
| SG11201811431VA (en) | Multispecific antibodies against cd40 and cd137 | |
| SG11201808108XA (en) | Synthesis of indazoles | |
| SG11201810628XA (en) | Nasal pharmaceutical compositions with a porous excipient | |
| SG11201810579YA (en) | Pyrimidin-2-ylamino-1h-pyrazols as lrrk2 inhibitors for use in the treatment of neurodegenerative disorders | |
| SG11201407580YA (en) | Composition comprising two antibodies engineered to have reduced and increased effector function | |
| SG11201906431UA (en) | Method for the treatment of thromboembolism | |
| SG11201407837WA (en) | Beta-hairpin peptidomimetics | |
| SG11201407397WA (en) | Formulations and methods for vaginal delivery of antiprogestins | |
| SG11201408251SA (en) | A pharmaceutical composition containing nicotinic acid and/or nicotinamide and/or tryptophan for positively influencing the intestinal microbiota | |
| SG11201808222RA (en) | Methods of treatment of cholestatic diseases | |
| SG11201408769QA (en) | Methods of reducing the risk of a cardiovascular event in a subject on statin therapy | |
| SG11201906436VA (en) | Novel heterocyclic compound, its preparation method, and pharmaceutical composition comprising the same | |
| SG11201807185UA (en) | Modified hyaluronic acid, method for making same and uses thereof | |
| SG11201408509PA (en) | Racecadotril lipid compositions | |
| SG11201407655TA (en) | Therapeutic uses of fibroblast growth factor 21 proteins | |
| SG11201804704PA (en) | Compositions and methods for decreasing tau expression | |
| SG11201805311XA (en) | Method of treating a mammal, including human, against cancer using methionine and asparagine depletion | |
| SG11201804965SA (en) | Augmented acid alpha-glucosidase for the treatment of pompe disease | |
| SG11201407536UA (en) | Topical pharmaceutical compositions comprising terbinafine and urea | |
| SG11201407575PA (en) | 5-amino[1,4]thiazines as bace 1 inhibitors | |
| SG11201809469QA (en) | [8-(phenylsulfonyl)-3,8-diazabicyclo[3.2.1]oct-3-yl] (1h-1,2,3-triazol-4-yl)methanones | |
| SG11201408230VA (en) | Therapeutic formulation and methods of treatment | |
| SG11201805142RA (en) | Pharmaceutical compositions comprising phenylaminopyrimidine derivative |